Company / Book Value per Share
Lilly (Eli) Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$29.376
FY2025
5-year range
$9.596 / $29.376
FY2021-FY2025
Trend
+86.2%
vs FY2024
Sector context
#15 of 209
Health Care
What the data says
Among 209 Health Care companies, Lilly (Eli) is in the top 7% for book value per share. Book Value per Share has increased for 6 consecutive years, from $2.478 in FY2019 to $29.376 in FY2025.
Based on SEC 10-K filings.
$29.376 in FY2025 with a 5-year CAGR of +40.0%. Top quartile in the Health Care sector.
Improved from $11.815 to $29.376 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +36.0%
- 5-Year CAGR
- +40.0%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 209This company $29.376 Sector average $215.686
▼
-86.4% below sector average
Key checks
Key Insights
- Lilly (Eli)'s book value per share has grown for 6 consecutive years.
- 5-year CAGR of +40.0%, indicating consistent growth.
- In FY2025, book value per share increased 86.2% year-over-year.
- Ranks #15 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $29.376 | +86.2% |
| FY2024 | $15.777 | +33.5% |
| FY2023 | $11.815 | +1.2% |
| FY2022 | $11.671 | +21.6% |
| FY2021 | $9.596 | +75.8% |
| FY2020 | $5.458 | +120.3% |
| FY2019 | $2.478 | -73.2% |
| FY2018 | $9.256 | -14.9% |
| FY2017 | $10.877 | -16.6% |
| FY2016 | $13.039 | -2.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026